Charles Schwab Investment Management Inc. Acquires 163,272 Shares of AdaptHealth Corp. $AHCO

Charles Schwab Investment Management Inc. boosted its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 14.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,301,652 shares of the company’s stock after buying an additional 163,272 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.97% of AdaptHealth worth $14,110,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. Reinhart Partners LLC. grew its position in shares of AdaptHealth by 15.5% in the first quarter. Reinhart Partners LLC. now owns 7,236,262 shares of the company’s stock valued at $78,441,000 after purchasing an additional 969,408 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of AdaptHealth by 17.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company’s stock valued at $32,174,000 after purchasing an additional 505,180 shares during the last quarter. Palisade Capital Management LP grew its stake in shares of AdaptHealth by 12.3% in the first quarter. Palisade Capital Management LP now owns 2,711,142 shares of the company’s stock worth $29,389,000 after acquiring an additional 297,268 shares during the last quarter. Bridgeway Capital Management LLC grew its stake in shares of AdaptHealth by 27.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 1,324,043 shares of the company’s stock worth $12,605,000 after acquiring an additional 283,143 shares during the last quarter. Finally, New Age Alpha Advisors LLC acquired a new stake in shares of AdaptHealth in the first quarter worth $2,503,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

Insider Activity at AdaptHealth

In other news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $9.73, for a total transaction of $79,786.00. Following the sale, the director directly owned 50,045 shares of the company’s stock, valued at $486,937.85. This represents a 14.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.55% of the stock is owned by company insiders.

AdaptHealth Price Performance

Shares of AHCO stock opened at $9.61 on Friday. AdaptHealth Corp. has a 52 week low of $7.11 and a 52 week high of $11.70. The stock’s fifty day moving average is $9.22 and its 200-day moving average is $9.24. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. The stock has a market capitalization of $1.30 billion, a PE ratio of 17.80, a PEG ratio of 1.07 and a beta of 1.58.

Analyst Upgrades and Downgrades

AHCO has been the topic of several research analyst reports. Wall Street Zen upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. Truist Financial decreased their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, May 12th. Finally, Royal Bank Of Canada decreased their target price on shares of AdaptHealth from $14.00 to $13.00 and set an “outperform” rating on the stock in a research report on Thursday, May 8th. Five research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.